Skip to main content

ClearThink 1 Acquisition Corp. Announces Closing of its $125,000,000 Initial Public Offering

BOCA RATON, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) — ClearThink 1 Acquisition Corp. (NASDAQ: CTAAU) (the “Company”) today announced the closing of its initial public offering of 12,500,000 units at $10.00 per unit, with each unit consisting of one Class A ordinary share and one right to receive one-fifth (1/5) of one Class A ordinary share at the closing of the Company’s initial business combination. The units began to trade on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “CTAAU” on February 24, 2026. Once the securities constituting the units begin separate trading, the Class A ordinary shares and share rights are expected to be listed on Nasdaq under the symbols “CTAA” and “CTAAR,” respectively. D. Boral Capital acted as the sole book-running manager for...

Continue reading

Toll Brothers Honored at The Nationals Awards by NAHB

Company Wins Seven Gold Awards and 28 Silver Awards for Stunning Model Home Designs Across the Country FORT WASHINGTON, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, was recently honored with seven Gold Award honors by the National Association of Home Builders (NAHB) at The Nationals, the home building industry’s highest awards competition. The prestigious awards are presented by the National Association of Home Builders Sales and Marketing Council to recognize the best in the building industry for their determination, integrity, creativity and endurance. The awards span categories from product and community design to advertising, marketing and sales achievements by individuals and sales teams.A panel of industry professionals selected finalists from more than...

Continue reading

Annual report 2025: Result as expected in a year focused on strengthening profitability and the foundation for growth

Announcement no. 04-2026 25 February 2026   North Media Group CEO Lasse Brodt on the development in 2025:”2025 was a year focused on stabilising multiple of our businesses and strengthening the foundation for increased profitability and future growth. On this basis, we delivered financial results in line with expectations under continuously challenging market conditions in both Denmark and Sweden. I am satisfied with the fact, that we finalised the implementation of automated packing of printed matter in Sweden, which was a significant milestone in the transformation of SDR towards the business model which FK Distribution utilises. We simultaneously adapted the business model in the Danish distribution business to be capable of addressing the changes we expect in the product mix over the coming years. In Digital Services, BoligPortal delivered...

Continue reading

Toll Brothers Announces Final Opportunity to Own a Luxury Home at Woodcrest Hills in Simpsonville, South Carolina

Limited homes remain available in this sought-after Five Forks community SIMPSONVILLE, S.C., Feb. 25, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the final opportunity for home shoppers to purchase a new luxury home at Woodcrest Hills, a boutique community located in Simpsonville, South Carolina. Only four new homes remain available for sale in this serene Five Forks enclave.Woodcrest Hills is offering the final selection of quick move-in homes priced from the low $400,000s with move-in dates as early as April 2026. Nestled in an idyllic and natural setting, the community features wooded home sites, open floor plans, and well-appointed kitchens designed to fit every lifestyle.“Woodcrest Hills offers home shoppers a unique combination of sophisticated...

Continue reading

Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution

DESMODA is the first and only FDA-approved desmopressin oral solution Commercial launch expected on March 9th DESMODA eliminates tablet splitting and crushing, enabling precise, individualized dosing for patients of all ages The product is expected to be a significant long-term growth contributor, with potential peak sales of $30-50 million annually and patent protection extending through 2044DEER PARK, Ill., Feb. 25, 2026 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced the U.S. Food and Drug Administration (FDA) approval of a New Drug Application (NDA) for DESMODA™ (desmopressin acetate) Oral Solution for the management of central diabetes insipidus, also...

Continue reading

T3 Defense Inc. Announces Private Placement of up to $20 Million to Accelerate Acquisition Strategy

Two-tranche financing strengthens balance sheet and supports disciplined expansion across defense industrial base NEW YORK and TEL AVIV, Israel, Feb. 25, 2026 (GLOBE NEWSWIRE) — T3 Defense Inc. (NASDAQ: DFNS), formerly Nukkleus Inc., today announced that it has entered into definitive agreements for a committed private investment for up to $20 million from Esousa Group Holdings, LLC, a New York-based family office and an existing shareholder. The financing is intended to accelerate the company’s disciplined roll-up strategy, consolidating and scaling high-value suppliers operating at structurally constrained points within the defense industrial base. The financing is structured in two tranches, with $10 million funded at closing and a second $10 million tranche committed, subject to an effective registration statement covering...

Continue reading

Danone: Notification of availability of Danone’s 2025 consolidated financial statements and statutory auditors’ report

Press Release – Paris, February 25, 2026, at 7pm CET Notification of availability of Danone’s 2025 consolidated financial statements and statutory auditors’ report Danone announces that its consolidated financial statements and the statutory auditors’ report for the fiscal year ended December 31, 2025 are publicly available and accessible online on its website, www.danone.com, section Investors / Financial and extra-financial reports. About Danone (www.danone.com)  Danone is a leading global food and beverage company operating in three health-focused, fast-growing and on-trend Categories: Essential Dairy & Plant-Based products, Waters and Specialized Nutrition. With a long-standing mission of bringing health through food to as many people as possible, Danone aims to inspire healthier and more sustainable eating and drinking practices...

Continue reading

Ilkka Oyj: Acquisition of own shares on 25 February 2026

Ilkka Oyj, Stock Exchange Release, 25 February 2026 at 07:00 p.m. EET Ilkka Oyj: Acquisition of own shares on 25 February 2026Date 25 February 2026  Exchange transaction Buy  Share trading code ILKKA2 FH  Amount, shares 1,547  Average price/share (EUR) 4.2548  Total cost (EUR) 6,582.18  After the acquisitions Ilkka Oyj holds a total of  91,855 treasury shares. On behalf of Ilkka Oyj Danske Bank A/S, Finland Branch Antti Väliaho                       Jonathan Nyberg For more information, please contact:Seija Peitso, CFO, Ilkka Oyjseija.peitso@ilkka.com Ilkka Oyj company descriptionAttachmentILKKA2.HE_20260225

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.